Sex differences in mortality and liver‐related events in non‐alcoholic fatty liver disease: A systematic review and meta‐analysis

Abstract

AbstractBackground & AimsMany systematic reviews explore the association of non‐alcoholic fatty liver disease (NAFLD) with mortality, but none of them explores sex‐based differences in detail. We aimed to assess whether NAFLD is associated with cause‐specific mortality, all‐cause mortality, and cancer incidence in both men and women.MethodsThe PubMed, Embase, and Medline databases were searched from inception through April 2023 for eligible studies. We separately pooled relative risks (RRs) for men and women using a random effects model. Subsequently, the RRs and 95% CIs (confidence intervals) in each study were used to calculate the women‐to‐men ratio of RRs (RRR). Furthermore, subgroup analyses were performed to explore the robustness of outcomes. The random‐effects model was employed to conduct sensitivity analyses to determine the impact of specific studies on the overall findings.ResultsThe meta‐analysis included nine cohort studies comprising 557 614 patients with NAFLD were chosen. Women were 44% more likely than men to get cancer among those with NAFLD (RRR: 1.44; 95% CI: 1.02–2.04; p = .039). However, no sex‐related differences were observed between NAFLD and all‐cause mortality (RRR: 1.06; 95% CI: 0.56–2.01; p = .861), liver‐related mortality (RRR: 1.06; 95% CI: 0.02–69.82; p = .977), cardiovascular mortality (RRR: 1; 95% CI: 0.65–1.53; p = .987) and liver cancer (RRR: 0.76; 95% CI: 0.43–1.36; p = .36).ConclusionsThere may be sex variations between NAFLD and the risk of cancer, with the connection being stronger in females than in males.